Certified by Founder Lodge 
                                        
                                        HealthCap
 
                                                 Sweden  -  Stockholm, Stockholm 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $135,000,000
                                            5 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            HealthCap is a family of venture capital funds investing globally in life sciences. With more than EUR 1.2 billion raised since the start in 1996, HealthCap is one of the largest specialized
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Hemab Therapeutics | 
                                                            February, 22 ,2023 | Series B | $135,000,000 | 
   Rampart Bioscience | 
                                                            October, 25 ,2023 | Series A | $85,000,000 | 
   Aro Biotherapeutics | 
                                                            November, 29 ,2023 | Series B | $41,500,000 | 
   SynOx Therapeutics | 
                                                            April, 23 ,2024 | Series B | $75,000,000 | 
   Tribune Therapeutics | 
                                                            March, 27 ,2025 | Seed | $39,883,965 | 
                                                
  Hemab Therapeutics
  Rampart Bioscience
  Aro Biotherapeutics
  SynOx Therapeutics
  Tribune Therapeutics
Cherry Ventures
 
                                            
Blue Bear Capital
 
                                            
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)